So I think a couple things on the question is we think that the best way to grow Impella is to improve outcomes for patients and that can be for enabling high-risk PCI patients to receive complete revascularization and protection from problems with acute kidney injury or keeping somebody alive after a heart attack that goes into shock and sending them home with their native heart